Rapid, fully automated digital immunoassay for p24 protein with the sensitivity of nucleic acid amplification for detecting acute HIV infection
BACKGROUND Nucleic acid testing (NAT) has become the standard for high sensitivity in
detecting low levels of virus. However, adoption of NAT can be cost prohibitive in low-
resource settings where access to extreme sensitivity could be clinically advantageous for
early detection of infection. We report development and preliminary validation of a simple,
low-cost, fully automated digital p24 antigen immunoassay with the sensitivity of quantitative
NAT viral load (NAT-VL) methods for detection of acute HIV infection. METHODS We …
detecting low levels of virus. However, adoption of NAT can be cost prohibitive in low-
resource settings where access to extreme sensitivity could be clinically advantageous for
early detection of infection. We report development and preliminary validation of a simple,
low-cost, fully automated digital p24 antigen immunoassay with the sensitivity of quantitative
NAT viral load (NAT-VL) methods for detection of acute HIV infection. METHODS We …
BACKGROUND
Nucleic acid testing (NAT) has become the standard for high sensitivity in detecting low levels of virus. However, adoption of NAT can be cost prohibitive in low-resource settings where access to extreme sensitivity could be clinically advantageous for early detection of infection. We report development and preliminary validation of a simple, low-cost, fully automated digital p24 antigen immunoassay with the sensitivity of quantitative NAT viral load (NAT-VL) methods for detection of acute HIV infection.
METHODS
We developed an investigational 69-min immunoassay for p24 capsid protein for use on a novel digital analyzer on the basis of single-molecule-array technology. We evaluated the assay for sensitivity by dilution of standardized preparations of p24, cultured HIV, and preseroconversion samples. We characterized analytical performance and concordance with 2 NAT-VL methods and 2 contemporary p24 Ag/Ab combination immunoassays with dilutions of viral isolates and samples from the earliest stages of HIV infection.
RESULTS
Analytical sensitivity was 0.0025 ng/L p24, equivalent to 60 HIV RNA copies/mL. The limit of quantification was 0.0076 ng/L, and imprecision across 10 runs was <10% for samples as low as 0.09 ng/L. Clinical specificity was 95.1%. Sensitivity concordance vs NAT-VL on dilutions of preseroconversion samples and Group M viral isolates was 100%.
CONCLUSIONS
The digital immunoassay exhibited >4000-fold greater sensitivity than contemporary immunoassays for p24 and sensitivity equivalent to that of NAT methods for early detection of HIV. The data indicate that NAT-level sensitivity for acute HIV infection is possible with a simple, low-cost digital immunoassay.
Oxford University Press